All coverage of this event, automatically grouped from multiple independent sources.
Last updated: 23 October 2026 at 21:22 · 10 articles · 1 sources
In data released at ESMO, the Moderna-Merck personalized mRNA cancer vaccine reduced recurrence-free survival and the time until distant metastasis occurred.
Read at STAT News · 23 October 2026 at 19:19
The American Diabetes Association has issued two explanations, two reviews and an apology over its June convention. A Friday report adds new twists.
Read at STAT News · 23 October 2026 at 19:16
Where should the safety bar be for studies investigating CAR-T therapies for autoimmune conditions?
Read at STAT News · 23 October 2026 at 18:55
Most new cancer medicines approved by European regulators over a recent four-year period do not offer high clinical benefit, a new analysis finds.
Read at STAT News · 23 October 2026 at 18:48
An MS treatment from Novartis cut by a third the rates of relapses compared to a standard treatment.
Read at STAT News · 23 October 2026 at 16:47
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
Read at STAT News · 23 October 2026 at 15:59
This week on the “The Readout LOUD” podcast, we remember our beloved colleague Helen Branswell, who died last week. We speak with colleagues, family, and public health leaders about her…
Read at STAT News · 23 October 2026 at 15:48
As the ESMO conference kicks off, Tango's pancreatic cancer combination shows striking promise and detailed data on Moderna and Merck's cancer vaccine is released early.
Read at STAT News · 23 October 2026 at 15:24
A new Treasury Department proposal would restrict U.S. investments in Chinese biotechs, but still allows licensing deals.
Read at STAT News · 23 October 2026 at 14:03
A personalized mRNA cancer vaccine reduced the risk of disease recurrence in patients with melanoma by 42% compared to a standard treatment
Read at STAT News · 23 October 2026 at 13:45